North Korea test fired an estimated 10 ballistic missiles March 14, 2026, from its KN-25 multiple rocket launcher system. Korean Central News Agency photo North Korea recently test fired an estimated ...
An experimental drug that Theravance Biopharma touted as a potential first-in-class medicine for multiple system atrophy has failed a Phase 3 study, triggering a corporate shakeup that ends this ...
– Company is advancing ATH434 in late-stage clinical development for Multiple System Atrophy, a rapidly progressive neurodegenerative disease with no approved therapies – MSA is a progressive ...
– Company is advancing ATH434 in late-stage clinical development for Multiple System Atrophy, a rapidly progressive neurodegenerative disease with no approved therapies – MELBOURNE, Australia and SAN ...
– Company is advancing ATH434 in late-stage clinical development for Multiple System Atrophy, a rapidly progressive neurodegenerative disease with no approved therapies – MELBOURNE, Australia and SAN ...
A student-run organization at the University of Missouri, Rockin’ Against Multiple Sclerosis, is hosting philanthropic events to raise money for the Multiple Sclerosis Institute while leaving a ...
SEOUL, Jan. 28 (UPI) --North Korean leader Kim Jong Un oversaw the test-firing of an upgraded large-caliber multiple rocket system, state-run media reported Wednesday. Kim said the test held "great ...
The FDA has granted 510(k) clearance to Medtronic for its MiniMed “Go Smart” multiple daily injection system — the first smart MDI system to automatically integrate insulin dosing and glucose data ...
Please provide your email address to receive an email when new articles are posted on . The MiniMed Go app received FDA 510(k) clearance for people with type 1 or type 2 diabetes requiring insulin.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results